NCT03413982Recruiting

Bladder Cancer Longitudinal Biorepository for Development of Novel Therapeutics/Biomarkers

University of Kansas Medical Center

Start Date

11/2/2017

Completion Date

1/1/2035

Summary

The purpose of this study is to create a registry, which is a "bank" of information about patients who have had similar medical conditions and treatments. The registry will be used by researchers to learn more about long term outcome of patients with bladder cancer, how bladder cancer tissues are related to tumor development, recurrence and survival.

Eligibility Criteria

Age Range: 18 years to No maximum

Inclusion Criteria: * Patients who present to clinic with presumed bladder cancer or have a diagnosis of bladder cancer are eligible to participate * Patients can participate in any additional research studies during the patients' participation within this protocol. Exclusion Criteria: * Patients who do not have presumed bladder cancer will not be eligible

Interventions

OTHER

Registry

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Bladder Cancer

Locations

University of Kansas Medical Center

Kansas City, Kansas 66160

United States

Run studies, or work at a research site?

Corterve helps sites and sponsors reach patients who are looking for trials. It does not determine eligibility and does not promise an enrolment outcome.

For sponsors, CROs and sites

What Corterve sells to organisations, and the anti-kickback constraints it works within.

Services and published prices

Lay summaries for EU CTR Annex V, pre-screen filtration, recruitment-creative regulatory operations, feasibility reporting.

For research sites

One published licence rate, the same for every site, and the fees a site is never charged.